Professor Anthony P. Davenport

Professor Anthony P. Davenport

University of Cambridge

H-index: 90

Europe-United Kingdom

About Professor Anthony P. Davenport

Professor Anthony P. Davenport, With an exceptional h-index of 90 and a recent h-index of 48 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of G-protein coupled receptors.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor

The IUPHAR/BPS guide to pharmaCOLOGY in 2024

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan

Endothelin receptors in GtoPdb v. 2023.1

Current and future strategies for targeting the endothelin pathway in cardiovascular disease

# 4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE

From ABCD to E for endothelin in resistant hypertension

Class A orphans in GtoPdb v. 2023.1

Professor Anthony P. Davenport Information

University

Position

___

Citations(all)

33511

Citations(since 2020)

11559

Cited By

26816

hIndex(all)

90

hIndex(since 2020)

48

i10Index(all)

273

i10Index(since 2020)

121

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Professor Anthony P. Davenport Skills & Research Interests

G-protein coupled receptors

Top articles of Professor Anthony P. Davenport

Title

Journal

Author(s)

Publication Date

Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor

Anthony Davenport

Thomas Williams

Rhoda Kuc

Robyn Macrae

Sanjay Sinha

...

2024/4/4

The IUPHAR/BPS guide to pharmaCOLOGY in 2024

Nucleic acids research

Simon D Harding

Jane F Armstrong

Elena Faccenda

Christopher Southan

Stephen PH Alexander

...

2024/1/5

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan

Frontiers in Pharmacology

Thomas L Williams

Duuamene Nyimanu

Rhoda E Kuc

Richard Foster

Robert C Glen

...

2024/4/9

Endothelin receptors in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

George R Abraham

Pedro D'Orléans-Juste

Anthony P Davenport

Théophile Godfraind

Janet J Maguire

...

2023/4/26

Current and future strategies for targeting the endothelin pathway in cardiovascular disease

George R Abraham

Thomas L Williams

Janet J Maguire

Peter J Greasley

Philip Ambery

...

2023/11

# 4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE

Nephrology Dialysis Transplantation

Fiona Chapman

Vanessa Melville

Lorraine Bruce

Janet Maguire

Anthony Davenport

...

2023/6

From ABCD to E for endothelin in resistant hypertension

Cell

George R Abraham

Anthony P Davenport

2023/1/19

Class A orphans in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Stephen PH Alexander

Jim Battey

Helen E Benson

Richard V Benya

Tom I Bonner

...

2023/4/26

The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets

British journal of pharmacology

Stephen PH Alexander

Eamonn Kelly

Alistair A Mathie

John A Peters

Emma L Veale

...

2023/10

# 3840 THE SYSTEMIC AND RENAL HAEMODYNAMIC EFFECTS OF APELIN IN HEALTH AND CHRONIC KIDNEY DISEASE

Nephrology Dialysis Transplantation

Fiona Chapman

Vanessa Melville

Lorraine Bruce

Janet Maguire

Anthony Davenport

...

2023/6

Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands

Frontiers in Endocrinology

Thomas L Williams

Robyn GC Macrae

Rhoda E Kuc

Alastair JH Brown

Janet J Maguire

...

2023/3/9

Precision Pharmacotherapy With Zibotentan in Microvascular Angina: a randomized, placebo-controlled, cross-over trial.

Colin Berry

Andrew Morrow

George Abraham

Stephen Hoole

John Greenwood

...

2023/12/21

Chemerin receptors in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Anthony P Davenport

Amy E Monaghan

2023/4/26

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

British journal of pharmacology

Stephen PH Alexander

Arthur Christopoulos

Anthony P Davenport

Eamonn Kelly

Alistair A Mathie

...

2023/10

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Nature

Teresa Brevini

Mailis Maes

Gwilym J Webb

Binu V John

Claudia D Fuchs

...

2023/3/2

Trace amine receptor in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Tom I Bonner

Anthony P Davenport

Stephen M Foord

Janet J Maguire

William AE Parker

2023/4/26

Targeting the apelin system for the treatment of cardiovascular diseases

Fiona A Chapman

Janet J Maguire

David E Newby

Anthony P Davenport

Neeraj Dhaun

2023/12

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

Jane F Armstrong

Brice Campo

Stephen PH Alexander

Lauren B Arendse

Xiu Cheng

...

2023/8

Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes

Cardiovascular Research

Robyn GC Macrae

Maria T Colzani

Thomas L Williams

Semih Bayraktar

Rhoda E Kuc

...

2023/2/1

Succinate receptor in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Anthony P Davenport

Julien Hanson

Wen Chiy Liew

2023/4/26

See List of Professors in Professor Anthony P. Davenport University(University of Cambridge)